iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 1169

Identifiers

  • Canonical SMILES:
    OC(=O)c1nc(sc1CCCOc1ccc(cc1)-c1cccnc1C#N)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1
  • IUPAC name:
    2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-(2-cyanopyridin-3-yl)phenoxy]propyl]-1,3-thiazole-4-carboxylic acid
  • InChi:
    InChI=1S/C36H28N6O4S2/c37-20-29-25(8-4-17-38-29)23-12-14-24(15-13-23)46-19-5-11-31-32(34(44)45)40-36(48-31)42-18-16-22-6-3-7-26(27(22)21-42)33(43)41-35-39-28-9-1-2-10-30(28)47-35/h1-4,6-10,12-15,17H,5,11,16,18-19,21H2,(H,44,45)(H,39,41,43)
  • InChiKey:
    IJTBMMJFSGGRLV-UHFFFAOYSA-N

External links


46836368

External search

Bibliography (1)

Publication Name
Jonathon Bayldon Baell, Chinh Thien Bui, Peter Colman, Peter Czabotar, Danette A. Dudley, Wayne J. Fairbrother, John A. Flygare, Guillaume Laurent Lassene, Chudi Ndubaku, George Nikolakopoulos, Brad Edmund Sleebs, Brian John Smith, Keith Geoffrey Watson, Steven W. Elmore, Lisa A. Hasvold, Andrew M. Petros, Andrew J. Souers, Zhi-Fu Tao, Le Wang, Xilu Wang, Kurt Deshayes, Genentech, Inc., The Walter And Eliza Hall Institute Of Medical Research, Abbott Laboratories. . Heterocyclic compounds and methods of use None. 58

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
BCL2-Like / BAX 6.51 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 672.16 g/mol
HBA 10
HBD 2
HBA + HBD 12
AlogP 8.25
TPSA 141.33
RB 10
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2010080503 58 BCL2
P10415

Biochemical assay Time-Resolved FRET pKi (inhibition constant, -log10) 6.51
Ta Structure Name Drugbank ID
0.5099 (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE DB07406
0.4454 N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide DB02295
0.4182 Faldaprevir DB11808
0.4167 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE DB08192
0.4125 Alpelisib DB12015
0.4059 N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide DB08677
0.4013 Acotiamide DB12482
0.4013 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE DB08788
0.4005 Ciluprevir DB05868
0.4000 PF-5190457 DB14870
0.3962 Vedroprevir DB12037
0.3933 XV638 DB02702
0.3894 INHIBITOR Q8467 OF DUPONT MERCK DB04609
0.3884 Ziritaxestat DB15403
0.3870 Lintitript DB04867